PB2101: TREATMENT OF AGGRESSIVE B-CELL LYMPHOMA WITH DA-EPOCH-R, A SINGLE CENTRE EXPERIENCE

Documenti analoghi

• PB2101: TREATMENT OF AGGRESSIVE B-CELL LYMPHOMA WITH DA-EPOCH-R, A SINGLE CENTRE EXPERIENCE
  di: E.-K. Dimitraki, et al.
  Pubblicazione: (2022-06-01)
• PB2140: ALLOGENEIC STEM CELL TRANSPLANTATION IN RARE T-NHL SUBTYPES: FOCUS ON AITL, MF/SS, HSTCL. A SINGLE BMT-UNIT EXPERIENCE.
  di: T. Tzenou, et al.
  Pubblicazione: (2022-06-01)
• P1179: PROGNOSIS OF PATIENTS WITH AGGRESSIVE REFRACTORY B-NHL TREATED WITH GLOFITAMAB IN REAL CLINICAL PRACTICE
  di: Liudmila Fedorova, et al.
  Pubblicazione: (2023-08-01)
• Immune effector cell-associated hemophagocytic lymphohistiocytosis-like syndrome during treatment with the bivalent CD20xCD3 bispecific antibody glofitamab
  di: Alberto Fresa, et al.
  Pubblicazione: (2026-04-01)
• PB2333: CAR-T CELL THERAPY IS A EXCELLENT STRATEGY FOR R/R B-NHL
  di: Liu Rui, et al.
  Pubblicazione: (2023-08-01)